While psychedelics can lead to powerful experiences and new insights, they don’t directly "fix" us or create lasting change ...

After decades of planning and a $250 million investment, Lykos Therapeutics' application for an inaugural psychedelic drug was "expected to be a shoo-in," the New York Times reported. The company ...

Review: New York producer P-Sol has hit on a super effective formula for starting the party, stitching together a selection of familiar samples and hooks, adding some beautifully dusty breaks and ...